Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Cellestis

2000 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
$368M LATEST DEAL AMOUNT
Description

Developer of medical diagnostic technologies. The company has developed and commercialized the QuantiFERON technology, a proprietary approach for early disease detection.

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Acquirer
Primary Office
  • 28358 Constellation Drive
  • Unit 698
  • Valencia, CA 91355
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Cellestis’s full profile, request a free trial.

Cellestis Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 29-Aug-2011 $368M 00.000 00000 Completed Generating Revenue
3. PIPE 12-Jun-2004 00.000 00.000 Completed Generating Revenue
2. IPO 24-Apr-2001 $4.99M 000.00 Completed Generating Revenue
1. Early Stage VC 01-Jan-2000 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Cellestis Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Mooroolbark Investments Venture Capital Minority 000 0000 000000 0